Secondaries Announced 11.1.17

IPO BOUTIQUE CLIENTS and IPO BOUTIQUE SECONDARY ALERTS CLIENTS received ALL this information to their inbox on a REAL TIME basis.

If having real-time alerts for secondary offerings would be an advantage to you, inquire about a subscription today!

Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis. For example, this is not to be interpreted as a Buy recommendation in the traditional sense of adding to your stock portfolio; this is a short term (usually one day or opening trade) time period.

Company: Intellia Therapeutics
Symbol: NTLA
Price: Last Trade $31.12
Trade Date: 11/2
Shares: 4.8 million ($150m cash raise)
Underwriter(s) : Credit Suisse, Jefferies, Leerink Partners
Description: They are a leading genome editing company focused on the development of proprietary, potentially curative therapeutics utilizing a biological tool known as CRISPR/Cas9.
Rating = Subscription Needed

Company: AMERI Holdings, Inc.
Symbol: AMRH
Price: Last Trade $6.51 (OTC)
Trade Date: 11/8
Shares: TBD
Underwriter(s) : Northland Capital Markets
Co-Manager(s): Barrington Research
Description: They specialize in delivering SAP cloud, digital and enterprise services to clients worldwide.
Rating = Subscription Needed
Note: Their common stock is presently quoted on the OTCQB under the symbol “AMRH”.

Company: Assembly Biosciences, Inc.
Symbol: ASMB
Price: Last Trade $28.58
Trade Date: 11/2
Shares: 1.8 million ($50 million cash raise)
Re-Offer Range: Subscription Needed
Underwriter(s) : Jefferies, William Blair
Description: Assembly Biosciences, Inc. is a clinical-stage public biotechnology company developing two innovative platform programs: an HBV program advancing a new class of oral therapeutic candidates for the treatment of hepatitis B virus (HBV) infection and a Microbiome program developing novel oral live biotherapeutic candidates, which are designed to treat disorders associated with the microbiome.
Rating = Subscription Needed